Surprising Prognosis for Normal ACS

St elevation acute coronary syndromes are typically caused by thrombotic obstruction of a coronary artery due to ruptured atherosclerosis plaque.

Sorpresivo pronóstico para los infartos con coronarias normales

However, there is a significant number of patients with similar clinical presentations but no evidence of obstructive coronary artery disease (CAD).


Read also: CTO in patients with acute myocardial infarction increases long term mortality.


In general, patients without obstructive CAD have better survival, but this might vary substantially depending on the underlying cause and risk factors.

 

The present study included 4793 consecutive patients undergoing ST elevation MI.  88% of these patients had obstructive CAD (≥50% stenosis), 6% had no obstructive CAD (1-49% stenosis) and 5% presented absolutely normal coronary arteries.

 

Patients without CAD were mostly young women with few risk factors. Follow up reached mean 2.6 years.


Read also: Primary angioplasty and multivessel lesions: how should we proceed?


Short term mortality (30 days) was lower both for patients with non-obstructive CAD (HR 0.49; p=0.0018) and for patients with normal coronary arteries (HR 0.31; p=0.021), compared to patients with obstructive CAD.

 

But surprisingly (and just the opposite of what was observed at 30 days) long term mortality with non-obstructive CAD resulted similar (HR 1.15; p=0.48), and for those with normal coronary arteries, it resulted significantly higher (HR 2.44; p<0.001) than that of patients with typical MI (even after adjusting by troponin level).

 

Cause of death was cardiovascular in 70% of cases with typical infarction, but in patients with non-obstructive CAD, it was only 38%, and 32% in patients with normal arteries.


Read also: Is Emergency Cardiac Surgery Necessary in TAVR?


In a population matched by sex and age, mortality resulted superior in patients with non-obstructive CAD.

 

Conclusion

Patients undergoing ST elevation MI that do not present significant obstruction to their coronary arteries have similar and even superior mortality than patients with typical MI. These data suggest that treating these patients involve far more than the routine angiography, and that it should include medication and close follow-up.

 

Original title: Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.

Reference: Hedvig Bille Andersson et al. Eur Heart J. 2018 Jan 7;39(2):102-110.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...